ID   HDAC7_HUMAN             Reviewed;         952 AA.
AC   Q8WUI4; B3KY08; B4DWI0; B4E0Q5; Q6P1W9; Q6W9G7; Q7Z4K2; Q7Z5I1;
AC   Q96K01; Q9BR73; Q9H7L0; Q9NW41; Q9NWA9; Q9NYK9; Q9UFU7;
DT   16-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   04-FEB-2015, entry version 148.
DE   RecName: Full=Histone deacetylase 7;
DE            Short=HD7;
DE            EC=3.5.1.98;
DE   AltName: Full=Histone deacetylase 7A;
DE            Short=HD7a;
GN   Name=HDAC7; Synonyms=HDAC7A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RA   Li S., Fischle W., Verdin E., Walsh M.J.;
RT   "A novel class II HDAC is associated with the transcriptional
RT   homeodomain repressor CCAAT displacement protein.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   5).
RA   Petrie K., Zelent A.;
RT   "Genomic organization of the human histone deacetylase 7 gene.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Zhi Y., Su E.W.;
RT   "Homo sapiens histone deacetylase 7A (HDAC7A), transcript variant 3.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 5; 6; 8 AND 9),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 220-952 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 651-952.
RC   TISSUE=Embryo, Mammary gland, Placenta, Spleen, Teratocarcinoma, and
RC   Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 242-952 (ISOFORM 1).
RC   TISSUE=B-cell, Colon, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-952 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EDNRA.
RX   PubMed=11262386; DOI=10.1074/jbc.C000909200;
RA   Lee H.-J., Chun M., Kandror K.V.;
RT   "Tip60 and HDAC7 interact with the endothelin receptor a and may be
RT   involved in downstream signaling.";
RL   J. Biol. Chem. 276:16597-16600(2001).
RN   [11]
RP   INTERACTION WITH HDAC3.
RX   PubMed=11466315; DOI=10.1074/jbc.M104935200;
RA   Fischle W., Dequiedt F., Fillion M., Hendzel M.J., Voelter W.,
RA   Verdin E.;
RT   "Human HDAC7 histone deacetylase activity is associated with HDAC3 in
RT   vivo.";
RL   J. Biol. Chem. 276:35826-35835(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=12239305; DOI=10.1128/JVI.76.20.10290-10298.2002;
RA   Bryant H., Farrell P.J.;
RT   "Signal transduction and transcription factor modification during
RT   reactivation of Epstein-Barr virus from latency.";
RL   J. Virol. 76:10290-10298(2002).
RN   [13]
RP   INTERACTION WITH KAT5.
RX   PubMed=12551922; DOI=10.1074/jbc.M210816200;
RA   Xiao H., Chung J., Kao H.-Y., Yang Y.-C.;
RT   "Tip60 is a co-repressor for STAT3.";
RL   J. Biol. Chem. 278:11197-11204(2003).
RN   [14]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-155 AND SER-181, AND
RP   MUTAGENESIS OF LEU-150; SER-155; SER-181; SER-358 AND SER-486.
RX   PubMed=16980613; DOI=10.1128/MCB.00231-06;
RA   Dequiedt F., Martin M., Von Blume J., Vertommen D., Lecomte E.,
RA   Mari N., Heinen M.F., Bachmann M., Twizere J.C., Huang M.C.,
RA   Rider M.H., Piwnica-Worms H., Seufferlein T., Kettmann R.;
RT   "New role for hPar-1 kinases EMK and C-TAK1 in regulating localization
RT   and activity of class IIa histone deacetylases.";
RL   Mol. Cell. Biol. 26:7086-7102(2006).
RN   [15]
RP   PHOSPHORYLATION AT SER-181.
RX   PubMed=17962809; DOI=10.1038/sj.emboj.7601891;
RA   von Blume J., Knippschild U., Dequiedt F., Giamas G., Beck A.,
RA   Auer A., Van Lint J., Adler G., Seufferlein T.;
RT   "Phosphorylation at Ser244 by CK1 determines nuclear localization and
RT   substrate targeting of PKD2.";
RL   EMBO J. 26:4619-4633(2007).
RN   [16]
RP   INTERACTION WITH KDM5B.
RX   PubMed=17373667; DOI=10.1002/ijc.22673;
RA   Barrett A., Santangelo S., Tan K., Catchpole S., Roberts K.,
RA   Spencer-Dene B., Hall D., Scibetta A., Burchell J., Verdin E.,
RA   Freemont P., Taylor-Papadimitriou J.;
RT   "Breast cancer associated transcriptional repressor PLU-1/JARID1B
RT   interacts directly with histone deacetylases.";
RL   Int. J. Cancer 121:265-275(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-283; THR-286
RP   AND SER-486, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION.
RX   PubMed=20188095; DOI=10.1016/j.febslet.2010.02.057;
RA   Harrison B.C., Huynh K., Lundgaard G.L., Helmke S.M., Perryman M.B.,
RA   McKinsey T.A.;
RT   "Protein kinase C-related kinase targets nuclear localization signals
RT   in a subset of class IIa histone deacetylases.";
RL   FEBS Lett. 584:1103-1110(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; SER-283 AND
RP   THR-286, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181 AND SER-486, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   INTERACTION WITH PML.
RX   PubMed=22155184; DOI=10.1053/j.gastro.2011.11.041;
RA   Satow R., Shitashige M., Jigami T., Fukami K., Honda K.,
RA   Kitabayashi I., Yamada T.;
RT   "Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor
RT   function in colorectal cancer cells.";
RL   Gastroenterology 142:572-581(2012).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 482-903, ZINC-BINDING SITES,
RP   AND MUTAGENESIS OF HIS-843.
RX   PubMed=18285338; DOI=10.1074/jbc.M707362200;
RA   Schuetz A., Min J., Allali-Hassani A., Schapira M., Shuen M.,
RA   Loppnau P., Mazitschek R., Kwiatkowski N.P., Lewis T.A.,
RA   Maglathin R.L., McLean T.H., Bochkarev A., Plotnikov A.N., Vedadi M.,
RA   Arrowsmith C.H.;
RT   "Human HDAC7 harbors a class IIa histone deacetylase-specific zinc
RT   binding motif and cryptic deacetylase activity.";
RL   J. Biol. Chem. 283:11355-11363(2008).
RN   [26]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-43.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes. Involved in muscle
CC       maturation by repressing transcription of myocyte enhancer factors
CC       such as MEF2A, MEF2B and MEF2C. During muscle differentiation, it
CC       shuttles into the cytoplasm, allowing the expression of myocyte
CC       enhancer factors (By similarity). May be involved in Epstein-Barr
CC       virus (EBV) latency, possibly by repressing the viral BZLF1 gene.
CC       {ECO:0000250, ECO:0000269|PubMed:12239305}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, NCOR1,
CC       NCOR2, SIN3A, SIN3B, RBBP4, RBBP7, MTA1L1, SAP30 and MBD3.
CC       Interacts with the 14-3-3 protein YWHAE, MEF2A, MEF2B and MEF2C
CC       (By similarity). Interacts with KAT5 and EDNRA. Interacts with
CC       KDM5B. Interacts with ZMYND15 (By similarity). Interacts with PML
CC       (isoform PML-4). {ECO:0000250, ECO:0000269|PubMed:11262386,
CC       ECO:0000269|PubMed:11466315, ECO:0000269|PubMed:12551922,
CC       ECO:0000269|PubMed:17373667, ECO:0000269|PubMed:22155184}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=2; IntAct=EBI-1048378, EBI-297353;
CC       Q9BZS1-1:FOXP3; NbExp=2; IntAct=EBI-1048378, EBI-9695448;
CC       P08393:ICP0 (xeno); NbExp=3; IntAct=EBI-1048378, EBI-6148881;
CC       Q9BZL6:PRKD2; NbExp=6; IntAct=EBI-1048378, EBI-1384325;
CC       P31947:SFN; NbExp=3; IntAct=EBI-1048378, EBI-476295;
CC       P63104:YWHAZ; NbExp=3; IntAct=EBI-1048378, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=In the nucleus, it
CC       associates with distinct subnuclear dot-like structures. Shuttles
CC       between the nucleus and the cytoplasm. Treatment with EDN1 results
CC       in shuttling from the nucleus to the perinuclear region. The
CC       export to cytoplasm depends on the interaction with the 14-3-3
CC       protein YWHAE and is due to its phosphorylation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=1;
CC         IsoId=Q8WUI4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WUI4-2; Sequence=VSP_007429, VSP_007431;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8WUI4-3; Sequence=VSP_008772;
CC       Name=4;
CC         IsoId=Q8WUI4-4; Sequence=VSP_007430;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q8WUI4-5; Sequence=VSP_038104;
CC       Name=6;
CC         IsoId=Q8WUI4-6; Sequence=VSP_038105;
CC       Name=7;
CC         IsoId=Q8WUI4-7; Sequence=VSP_038104, VSP_008772;
CC       Name=8;
CC         IsoId=Q8WUI4-8; Sequence=VSP_038106, VSP_038107;
CC       Name=9;
CC         IsoId=Q8WUI4-9; Sequence=VSP_038102;
CC       Name=10;
CC         IsoId=Q8WUI4-10; Sequence=VSP_038103;
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between
CC       the nucleus and the cytoplasm. {ECO:0000250}.
CC   -!- PTM: May be phosphorylated by CaMK1. Phosphorylated by the PKC
CC       kinases PKN1 and PKN2, impairing nuclear import. Phosphorylation
CC       at Ser-155 by MARK2, MARK3 and PRKD1 promotes interaction with 14-
CC       3-3 proteins and export from the nucleus. Phosphorylation at Ser-
CC       155 is a prerequisite for phosphorylation at Ser-181.
CC       {ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:17962809,
CC       ECO:0000269|PubMed:18669648, ECO:0000269|PubMed:19690332,
CC       ECO:0000269|PubMed:20068231, ECO:0000269|PubMed:20188095,
CC       ECO:0000269|PubMed:21406692}.
CC   -!- MISCELLANEOUS: Its activity is inhibited by Trichostatin A (TSA),
CC       a known histone deacetylase inhibitor. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF63491.1; Type=Frameshift; Positions=877; Evidence={ECO:0000305};
CC       Sequence=BAA91474.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA91545.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB15759.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB55363.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC56929.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF239243; AAF63491.1; ALT_FRAME; mRNA.
DR   EMBL; AY302468; AAQ18232.1; -; mRNA.
DR   EMBL; AY321367; AAP84704.1; -; mRNA.
DR   EMBL; BT009771; AAP88773.1; -; mRNA.
DR   EMBL; AK001032; BAA91474.1; ALT_INIT; mRNA.
DR   EMBL; AK001190; BAA91545.1; ALT_INIT; mRNA.
DR   EMBL; AK024469; BAB15759.1; ALT_INIT; mRNA.
DR   EMBL; AK027781; BAB55363.1; ALT_INIT; mRNA.
DR   EMBL; AK122588; BAC56929.1; ALT_SEQ; mRNA.
DR   EMBL; AK128383; BAG54670.1; -; mRNA.
DR   EMBL; AK299292; BAG61307.1; -; mRNA.
DR   EMBL; AK301545; BAG63042.1; -; mRNA.
DR   EMBL; AK303481; BAG64517.1; -; mRNA.
DR   EMBL; AC004466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW57957.1; -; Genomic_DNA.
DR   EMBL; BC006453; AAH06453.2; -; mRNA.
DR   EMBL; BC020505; AAH20505.2; -; mRNA.
DR   EMBL; BC064840; AAH64840.1; -; mRNA.
DR   EMBL; AL117455; CAB55935.1; -; mRNA.
DR   CCDS; CCDS41776.1; -. [Q8WUI4-7]
DR   CCDS; CCDS8756.2; -. [Q8WUI4-5]
DR   PIR; T17245; T17245.
DR   RefSeq; NP_001091886.1; NM_001098416.2. [Q8WUI4-7]
DR   RefSeq; NP_056216.2; NM_015401.3. [Q8WUI4-5]
DR   RefSeq; XP_005269025.1; XM_005268968.1. [Q8WUI4-6]
DR   UniGene; Hs.200063; -.
DR   PDB; 3C0Y; X-ray; 2.10 A; A/B/C=482-903.
DR   PDB; 3C0Z; X-ray; 2.10 A; A/B/C=482-903.
DR   PDB; 3C10; X-ray; 2.00 A; A/B/C=482-903.
DR   PDB; 3ZNR; X-ray; 2.40 A; A/B/C=482-903.
DR   PDB; 3ZNS; X-ray; 2.45 A; A/B/C=482-903.
DR   PDBsum; 3C0Y; -.
DR   PDBsum; 3C0Z; -.
DR   PDBsum; 3C10; -.
DR   PDBsum; 3ZNR; -.
DR   PDBsum; 3ZNS; -.
DR   ProteinModelPortal; Q8WUI4; -.
DR   SMR; Q8WUI4; 515-900.
DR   BioGrid; 119613; 126.
DR   DIP; DIP-29860N; -.
DR   IntAct; Q8WUI4; 19.
DR   MINT; MINT-3089050; -.
DR   BindingDB; Q8WUI4; -.
DR   ChEMBL; CHEMBL2716; -.
DR   GuidetoPHARMACOLOGY; 2661; -.
DR   PhosphoSite; Q8WUI4; -.
DR   DMDM; 30913097; -.
DR   MaxQB; Q8WUI4; -.
DR   PaxDb; Q8WUI4; -.
DR   PRIDE; Q8WUI4; -.
DR   DNASU; 51564; -.
DR   Ensembl; ENST00000080059; ENSP00000080059; ENSG00000061273. [Q8WUI4-5]
DR   Ensembl; ENST00000354334; ENSP00000351326; ENSG00000061273. [Q8WUI4-7]
DR   Ensembl; ENST00000427332; ENSP00000404394; ENSG00000061273. [Q8WUI4-1]
DR   Ensembl; ENST00000552960; ENSP00000448532; ENSG00000061273. [Q8WUI4-6]
DR   GeneID; 51564; -.
DR   KEGG; hsa:51564; -.
DR   UCSC; uc001rqe.3; human. [Q8WUI4-9]
DR   UCSC; uc001rqj.4; human. [Q8WUI4-7]
DR   UCSC; uc001rqk.5; human. [Q8WUI4-1]
DR   UCSC; uc010slo.2; human. [Q8WUI4-5]
DR   CTD; 51564; -.
DR   GeneCards; GC12M048176; -.
DR   H-InvDB; HIX0129669; -.
DR   HGNC; HGNC:14067; HDAC7.
DR   HPA; HPA004775; -.
DR   MIM; 606542; gene.
DR   neXtProt; NX_Q8WUI4; -.
DR   PharmGKB; PA162390579; -.
DR   eggNOG; COG0123; -.
DR   GeneTree; ENSGT00530000062809; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q8WUI4; -.
DR   KO; K11408; -.
DR   OrthoDB; EOG7RFTH5; -.
DR   PhylomeDB; Q8WUI4; -.
DR   TreeFam; TF106174; -.
DR   BRENDA; 3.5.1.98; 2681.
DR   Reactome; REACT_118780; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; REACT_160243; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; REACT_160254; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   ChiTaRS; HDAC7; human.
DR   EvolutionaryTrace; Q8WUI4; -.
DR   GeneWiki; HDAC7; -.
DR   GenomeRNAi; 51564; -.
DR   NextBio; 55370; -.
DR   PMAP-CutDB; Q8WUI4; -.
DR   PRO; PR:Q8WUI4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; Q8WUI4; -.
DR   CleanEx; HS_HDAC7; -.
DR   ExpressionAtlas; Q8WUI4; baseline and differential.
DR   Genevestigator; Q8WUI4; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000118; C:histone deacetylase complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0007043; P:cell-cell junction assembly; IEA:Ensembl.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Hydrolase; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Zinc.
FT   CHAIN         1    952       Histone deacetylase 7.
FT                                /FTId=PRO_0000114705.
FT   REGION        1    268       Transcription repression 1.
FT                                {ECO:0000250}.
FT   REGION        1     98       Interaction with MEF2C. {ECO:0000250}.
FT   REGION       49    149       Interaction with MEF2A. {ECO:0000250}.
FT   REGION      218    546       Transcription repression 2.
FT                                {ECO:0000250}.
FT   REGION      518    865       Histone deacetylase.
FT   REGION      877    952       Interaction with SIN3A. {ECO:0000250}.
FT   MOTIF       918    952       Nuclear export signal. {ECO:0000250}.
FT   COMPBIAS    197    203       Poly-Ser.
FT   COMPBIAS    368    373       Poly-Pro.
FT   ACT_SITE    670    670       {ECO:0000250}.
FT   METAL       533    533       Zinc.
FT   METAL       535    535       Zinc.
FT   METAL       541    541       Zinc.
FT   METAL       618    618       Zinc.
FT   SITE        843    843       Contributes to catalysis.
FT   MOD_RES     109    109       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES     155    155       Phosphoserine; by MARK2, MARK3 and
FT                                PKD/PRKD1. {ECO:0000305|PubMed:16980613}.
FT   MOD_RES     181    181       Phosphoserine; by PKD/PRKD2.
FT                                {ECO:0000269|PubMed:16980613,
FT                                ECO:0000269|PubMed:17962809,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     283    283       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     286    286       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     358    358       Phosphoserine; by PKD/PRKD1.
FT                                {ECO:0000250}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:21406692}.
FT   VAR_SEQ       1    527       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038102.
FT   VAR_SEQ       1    472       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007429.
FT   VAR_SEQ       1    338       Missing (in isoform 10).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_038103.
FT   VAR_SEQ       1      1       M -> MHSPGADGTQVSPGAHYCSPTGAGCPRPCADTPGPQ
FT                                PQPM (in isoform 5 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038104.
FT   VAR_SEQ       1      1       M -> MHSPGAGCPRPCADTPGPQPQPM (in isoform
FT                                6). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038105.
FT   VAR_SEQ       1      1       M -> MSDLRKRELGALFTSRGTGGVEWDGTQVSPGAHYCS
FT                                PTGAGCPRPCADTPGPQPQPM (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038106.
FT   VAR_SEQ     227    263       Missing (in isoform 3 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_008772.
FT   VAR_SEQ     227    256       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_007430.
FT   VAR_SEQ     473    520       LAQGGHRPLSRAQSSPAAPASLSAPEPASQARVLSSSETPA
FT                                RTLPFTT -> MQACVGVRGVYPPGSMWVPAVAVLACSLQP
FT                                RPWGVRTPWVPALTLAPA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_007431.
FT   VAR_SEQ     892    952       SKYWGCMQRLASCPDSWVPRVPGADKEEVEAVTALASLSVG
FT                                ILAEDRPSEQLVEEEEPMNL -> MGALTLSQIPGHGSSQQ
FT                                QAGGAFSRPGHPCRAAVVMVNTGAACSAWPPVQTPGCLECQ
FT                                GLTKKKWRQ (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038107.
FT   VARIANT      43     43       V -> M (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036043.
FT   MUTAGEN     150    150       L->A: Abolishes phosphorylation at S-155.
FT                                {ECO:0000269|PubMed:16980613}.
FT   MUTAGEN     155    155       S->A: Abolishes nuclear export; when
FT                                associated with A-181; A-358 and A-486.
FT                                Abolishes phosphorylation by MARK2 and
FT                                MARK3, interaction with 14-3-3 and
FT                                localization to the cytoplasm.
FT                                {ECO:0000269|PubMed:16980613}.
FT   MUTAGEN     181    181       S->A: Abolishes nuclear export; when
FT                                associated with A-155; A-358 and A-486.
FT                                {ECO:0000269|PubMed:16980613}.
FT   MUTAGEN     358    358       S->A: Abolishes nuclear export; when
FT                                associated with A-192; A-1118 and A-486.
FT                                {ECO:0000269|PubMed:16980613}.
FT   MUTAGEN     486    486       S->A: Abolishes nuclear export; when
FT                                associated with A-192; A-1118 and A-358.
FT                                {ECO:0000269|PubMed:16980613}.
FT   MUTAGEN     843    843       H->A: Enhanced deacetylase activity.
FT                                {ECO:0000269|PubMed:18285338}.
FT   MUTAGEN     843    843       H->F: Enhanced deacetylase activity.
FT                                {ECO:0000269|PubMed:18285338}.
FT   MUTAGEN     843    843       H->Y: 6000 fold increase in deacetylase
FT                                activity. {ECO:0000269|PubMed:18285338}.
FT   CONFLICT     50     50       M -> T (in Ref. 5; BAG64517).
FT                                {ECO:0000305}.
FT   CONFLICT    225    264       Missing (in Ref. 1; AAF63491).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       P -> L (in Ref. 5; BAA91545).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       R -> L (in Ref. 5; BAA91545).
FT                                {ECO:0000305}.
FT   CONFLICT    614    614       V -> E (in Ref. 1; AAF63491).
FT                                {ECO:0000305}.
FT   CONFLICT    644    644       S -> R (in Ref. 5; BAB15759).
FT                                {ECO:0000305}.
FT   CONFLICT    665    665       R -> W (in Ref. 5; BAA91474).
FT                                {ECO:0000305}.
FT   CONFLICT    700    700       K -> KASK (in Ref. 1; AAF63491).
FT                                {ECO:0000305}.
FT   CONFLICT    750    750       G -> S (in Ref. 5; BAA91545).
FT                                {ECO:0000305}.
FT   CONFLICT    777    777       A -> T (in Ref. 5; BAB55363).
FT                                {ECO:0000305}.
FT   CONFLICT    825    825       Q -> H (in Ref. 5; BAA91474).
FT                                {ECO:0000305}.
FT   STRAND      520    523       {ECO:0000244|PDB:3C10}.
FT   HELIX       526    530       {ECO:0000244|PDB:3C10}.
FT   HELIX       538    540       {ECO:0000244|PDB:3C10}.
FT   HELIX       546    557       {ECO:0000244|PDB:3C10}.
FT   HELIX       561    563       {ECO:0000244|PDB:3C10}.
FT   STRAND      564    567       {ECO:0000244|PDB:3C10}.
FT   HELIX       574    577       {ECO:0000244|PDB:3C10}.
FT   TURN        578    580       {ECO:0000244|PDB:3C10}.
FT   HELIX       583    590       {ECO:0000244|PDB:3C10}.
FT   HELIX       601    609       {ECO:0000244|PDB:3C10}.
FT   STRAND      621    626       {ECO:0000244|PDB:3C10}.
FT   TURN        631    633       {ECO:0000244|PDB:3C10}.
FT   HELIX       634    653       {ECO:0000244|PDB:3C10}.
FT   STRAND      656    662       {ECO:0000244|PDB:3C10}.
FT   STRAND      680    682       {ECO:0000244|PDB:3C10}.
FT   HELIX       684    695       {ECO:0000244|PDB:3C10}.
FT   STRAND      701    705       {ECO:0000244|PDB:3C10}.
FT   STRAND      707    709       {ECO:0000244|PDB:3C10}.
FT   HELIX       712    718       {ECO:0000244|PDB:3C10}.
FT   STRAND      724    731       {ECO:0000244|PDB:3C10}.
FT   TURN        733    736       {ECO:0000244|PDB:3C10}.
FT   HELIX       750    752       {ECO:0000244|PDB:3C10}.
FT   STRAND      756    761       {ECO:0000244|PDB:3C10}.
FT   STRAND      765    767       {ECO:0000244|PDB:3C10}.
FT   HELIX       771    780       {ECO:0000244|PDB:3C10}.
FT   HELIX       782    789       {ECO:0000244|PDB:3C10}.
FT   STRAND      792    798       {ECO:0000244|PDB:3C10}.
FT   HELIX       808    810       {ECO:0000244|PDB:3C10}.
FT   HELIX       817    827       {ECO:0000244|PDB:3C10}.
FT   HELIX       831    833       {ECO:0000244|PDB:3C10}.
FT   STRAND      835    839       {ECO:0000244|PDB:3C10}.
FT   HELIX       845    860       {ECO:0000244|PDB:3C10}.
FT   HELIX       866    868       {ECO:0000244|PDB:3C10}.
FT   HELIX       871    873       {ECO:0000244|PDB:3C10}.
FT   HELIX       878    891       {ECO:0000244|PDB:3C10}.
FT   TURN        892    894       {ECO:0000244|PDB:3C10}.
FT   HELIX       896    898       {ECO:0000244|PDB:3C10}.
SQ   SEQUENCE   952 AA;  102927 MW;  786785B084667731 CRC64;
     MDLRVGQRPP VEPPPEPTLL ALQRPQRLHH HLFLAGLQQQ RSVEPMRLSM DTPMPELQVG
     PQEQELRQLL HKDKSKRSAV ASSVVKQKLA EVILKKQQAA LERTVHPNSP GIPYRTLEPL
     ETEGATRSML SSFLPPVPSL PSDPPEHFPL RKTVSEPNLK LRYKPKKSLE RRKNPLLRKE
     SAPPSLRRRP AETLGDSSPS SSSTPASGCS SPNDSEHGPN PILGSEALLG QRLRLQETSV
     APFALPTVSL LPAITLGLPA PARADSDRRT HPTLGPRGPI LGSPHTPLFL PHGLEPEAGG
     TLPSRLQPIL LLDPSGSHAP LLTVPGLGPL PFHFAQSLMT TERLSGSGLH WPLSRTRSEP
     LPPSATAPPP PGPMQPRLEQ LKTHVQVIKR SAKPSEKPRL RQIPSAEDLE TDGGGPGQVV
     DDGLEHRELG HGQPEARGPA PLQQHPQVLL WEQQRLAGRL PRGSTGDTVL LPLAQGGHRP
     LSRAQSSPAA PASLSAPEPA SQARVLSSSE TPARTLPFTT GLIYDSVMLK HQCSCGDNSR
     HPEHAGRIQS IWSRLQERGL RSQCECLRGR KASLEELQSV HSERHVLLYG TNPLSRLKLD
     NGKLAGLLAQ RMFVMLPCGG VGVDTDTIWN ELHSSNAARW AAGSVTDLAF KVASRELKNG
     FAVVRPPGHH ADHSTAMGFC FFNSVAIACR QLQQQSKASK ILIVDWDVHH GNGTQQTFYQ
     DPSVLYISLH RHDDGNFFPG SGAVDEVGAG SGEGFNVNVA WAGGLDPPMG DPEYLAAFRI
     VVMPIAREFS PDLVLVSAGF DAAEGHPAPL GGYHVSAKCF GYMTQQLMNL AGGAVVLALE
     GGHDLTAICD ASEACVAALL GNRVDPLSEE GWKQKPNLNA IRSLEAVIRV HSKYWGCMQR
     LASCPDSWVP RVPGADKEEV EAVTALASLS VGILAEDRPS EQLVEEEEPM NL
//
